About Interleukin-10 receptor subunit beta
Interleukin-10 receptor subunit beta (IL10RB) is a protein
from Homo sapiens identified by UniProt accession
Q08334, 325 residues long.
MolForge cross-references it against 0 known binders and
346 disease associations.
Target properties
| Protein name | Interleukin-10 receptor subunit beta |
| UniProt accession | Q08334 |
| Gene | IL10RB |
| Organism | Homo sapiens |
| Length | 325 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (346)
Diseases linked to this target (Open Targets).
- inflammatory bowel disease 25 · score 0.73
- Autosomal recessive early-onset inflammatory bowel disease · score 0.65
- immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome · score 0.55
- inflammatory bowel disease · score 0.42
- hepatitis C virus infection · score 0.39
- ulcerative colitis · score 0.37
- COVID-19 · score 0.37
- interleukin-10 receptor B measurement · score 0.36
- hepatitis D virus infection · score 0.29
- chronic hepatitis C virus infection · score 0.28
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q08334-F1 | alphafold | PREDICTED | 82.14 | — |
Amino-acid sequence (325 residues)
MAWSLGSWLG GCLLVSALGM VPPPENVRMN SVNFKNILQW ESPAFAKGNL TFTAQYLSYR IFQDKCMNTT LTECDFSSLS KYGDHTLRVR AEFADEHSDW VNITFCPVDD TIIGPPGMQV EVLADSLHMR FLAPKIENEY ETWTMKNVYN SWTYNVQYWK NGTDEKFQIT PQYDFEVLRN LEPWTTYCVQ VRGFLPDRNK AGEWSEPVCE QTTHDETVPS WMVAVILMAS VFMVCLALLG CFALLWCVYK KTKYAFSPRN SLPQHLKEFL GHPHHNTLLF FSFPLSDEND VFDKLSVIAE DSESGKQNPG DSCSLGTPPG QGPQS
Explore Interleukin-10 receptor subunit beta with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets